Clinical Trials in Massachusetts

Showing 6601-6620 of 17,868 trials

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

NCT04547998

This is a prospective blinded within-subject randomized study to evaluate the application of Spray-On Skin™ Cells, prepared using the RECELL® Device for safe and effective repigmentation of ablated stable vitiligo lesions.

Vitiligo

Avita Medical25 participantsStarted Sep 2020

Irvine, California, United States • Sacramento, California, United States • San Diego, California, United States +9 more locations

TERMINATEDPhase 2/314 miles

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

NCT03896945

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786, as compared with placebo, for the treatment of negative symptoms of schizophrenia.

Schizophrenia

Otsuka Pharmaceutical Development & Commercialization, Inc.136 participantsStarted Feb 2019

Little Rock, Arkansas, United States • Anaheim, California, United States • Bellflower, California, United States +69 more locations

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Find Trials by Condition in Massachusetts

Diuretic Comparison Project

Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

A Study to Evaluate Ketamine for the Treatment of Rett Syndrome

Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease

Use of Oxandrolone to Promote Growth in Infants With HLHS

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD

IN.PACT™ AV Access IDE Study

Blinatumomab in Adults With Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders

Safety and Efficacy of Emixustat in Stargardt Disease

Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)